Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNBLS.L Regulatory News (NBLS)

  • There is currently no data for NBLS

Conversion of Securities

4 Jan 2019 15:05

RNS Number : 2787M
NB Global Floating Rate Income Fund
04 January 2019
 

4 January 2019

 

NB Global Floating Rate Income Fund Limited

(the "Company")

 

Conversion between Share Classes

 

The Company today announces the conversion of a number of US Dollar Shares into Sterling Shares (the "Conversion"). On the basis of the net asset values of the Company's shares as at 31 December 2018 (and also spot currency exchange rates as appropriate, in each case as at 31 December 2018), the conversion ratio, calculated in accordance with the Company's articles of incorporation, is as follows:

 

USD to GBP 0.80674846

 

On the basis of the aggregate level of conversion notices received by the Company, application will be made for the admission of 155,787 Sterling Shares to the Official List of the UK Listing Authority (the "Official List") and the main market for listed securities of the London Stock Exchange plc (the "Main Market"). Application will also be made for the cancellation of the listing on the Official List and the Main Market of 193,105 US Dollar Shares. It is expected that such application will become effective and that dealing in the Sterling Shares will commence on 11 January 2019. Accordingly, the Company's issued share capital with effect from 11 January 2019 will be as follows:

 

803,445,731 Sterling Shares (75,000,000 are held in Treasury as at 4 January 2019)

59,078,872 US Dollar Shares (1,342,627 are held in Treasury as at 4 January 2019)

 

Sterling Shares have 1.6 votes per share and US Dollar Shares have 1 vote per share. Following Conversion (which is expected to take place on 11 January 2019) the total number of voting rights in the Company will be 1,223,249,414. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interests in the Company under the FCA's Disclosure guidance and Transparency Rules.

 

Unless otherwise defined, capitalised terms shall have the meaning given to them in the prospectus of the Company dated 30 September 2013.

 

Note: The issued share capital and total voting rights with effect from 4 January 2019 may be subject to change due to the current on-going transactions in own shares of the Company.

 

The conversion dates for 2019 are set out below. In accordance with the Prospectus, Shareholders wishing to convert their Shares must give the Company 10 Business Days' notice in advance of the first Business Day of each calendar month.

 

Conversion Date

Dates by which elections for conversion must be received

12 February 2019

18 January 2019

12 March 2019

15 February 2019

10 April 2019

18 March 2019

14 May 2019

15 April 2019

12 June 2019

17 May 2019

10 July 2019

17 June 2019

12 August 2019

18 July 2019

11 September 2019

16 August 2019

10 October 2019

17 September 2019

12 November 2019

18 October 2019

11 December 2019

18 November 2019

13 January 2020

16 December 2019

 

ENDS

 

 

Carey

Company Secretary

Sara Bourne

+44 (0) 1481 737 245

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CONLLFIELSISIIA
Date   Source Headline
9th Jun 20206:00 pmRNSNet Asset Value(s)
9th Jun 20207:00 amRNSTransaction in Own Shares
8th Jun 20206:00 pmRNSNet Asset Value(s)
5th Jun 20206:00 pmRNSNet Asset Value(s)
5th Jun 20207:00 amRNSTransaction in Own Shares
4th Jun 20206:00 pmRNSNet Asset Value(s)
4th Jun 20207:00 amRNSTransaction in Own Shares
3rd Jun 20206:00 pmRNSNet Asset Value(s)
3rd Jun 20205:25 pmRNSConversion of Securities
3rd Jun 20207:00 amRNSTransaction in Own Shares
2nd Jun 20206:00 pmRNSNet Asset Value(s)
2nd Jun 202010:01 amRNSBlock listing Interim Review
2nd Jun 20207:00 amRNSTransaction in Own Shares
1st Jun 20206:00 pmRNSNet Asset Value(s)
1st Jun 20208:59 amRNSTotal Voting Rights
1st Jun 20208:59 amRNSTransaction in Own Shares
29th May 20206:00 pmRNSNet Asset Value(s)
29th May 20207:00 amRNSTransaction in Own Shares
28th May 20206:00 pmRNSNet Asset Value(s)
28th May 20207:00 amRNSTransaction in Own Shares
27th May 20206:00 pmRNSNet Asset Value(s)
27th May 20207:00 amRNSTransaction in Own Shares
26th May 20206:00 pmRNSNet Asset Value(s)
22nd May 20206:00 pmRNSNet Asset Value(s)
22nd May 20207:00 amRNSTransaction in Own Shares
21st May 20206:00 pmRNSNet Asset Value(s)
20th May 20206:00 pmRNSNet Asset Value(s)
20th May 20207:00 amRNSTransaction in Own Shares
19th May 20206:00 pmRNSNet Asset Value(s)
18th May 20206:00 pmRNSNet Asset Value(s)
18th May 20207:00 amRNSPortfolio Update - April 2020
18th May 20207:00 amRNSTransaction in Own Shares
15th May 20206:00 pmRNSNet Asset Value(s)
14th May 20206:00 pmRNSNet Asset Value(s)
13th May 20206:00 pmRNSNet Asset Value(s)
12th May 20206:00 pmRNSNet Asset Value(s)
11th May 20206:00 pmRNSNet Asset Value(s)
7th May 20206:00 pmRNSNet Asset Value(s)
6th May 20206:00 pmRNSNet Asset Value(s)
5th May 20206:00 pmRNSNet Asset Value(s)
5th May 20205:58 pmRNSConversion of Securities
4th May 20206:00 pmRNSNet Asset Value(s)
1st May 20206:00 pmRNSNet Asset Value(s)
30th Apr 20206:00 pmRNSNet Asset Value(s)
29th Apr 20206:00 pmRNSNet Asset Value(s)
28th Apr 20206:00 pmRNSNet Asset Value(s)
28th Apr 202011:55 amRNSArticles of Incorporation re LR 9.2.6ER(1)
27th Apr 20206:00 pmRNSNet Asset Value(s)
24th Apr 20206:00 pmRNSNet Asset Value(s)
23rd Apr 20206:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.